Table 2 Subgroup analysis.
Subgroup | No of study | No of patients | Random-effect model | I 2 (%) | Test of heterogeneity P | ||
|---|---|---|---|---|---|---|---|
Early RRT | Late RRT | Risk Ratio | 95% CI | ||||
Study population | |||||||
Surgical | 4 | 259 | 268 | 0.52 | 0.27–0.99 | 77 | 0.005 |
Mixed | 7 | 872 | 843 | 10.4 | 0.93–1.17 | 0 | 0.71 |
Study design | |||||||
Single center | 4 | 249 | 262 | 0.51 | 0.20–129 | 81 | 0.001 |
Multicenter | 7 | 882 | 849 | 1.02 | 0.91–1.14 | 0 | 0.96 |
Modality of RRT | |||||||
IHD only | 2 | 123 | 129 | 0.62 | 0.06–6.53 | 80 | 0.02 |
CRRT only | 6 | 403 | 380 | 0.85 | 0.59–1.21 | 73 | 0.002 |
Mixed | 3 | 605 | 602 | 1.01 | 0.88–1.15 | 0 | 0.70 |
Portion of patients with sepsis | |||||||
100% | 2 | 283 | 281 | 1.10 | 0.91–1.32 | 0 | 0.57 |
>50–<100% | 3 | 417 | 420 | 0.98 | 0.84–1.14 | 0 | 0.88 |
Study site | |||||||
Europe | 6 | 888 | 856 | 0.94 | 0.76–116 | 63 | 0.02 |
Asia | 4 | 195 | 203 | 0.66 | 0.28–1.56 | 78 | 0.003 |
North America | 1 | 48 | 52 | 1.03 | 0.62–1.71 | NA | NA |